Today: 21 May 2026
Palantir Stock Gets Fresh $208 Buy Call — But Can It Grow Fast Enough?
22 January 2026
2 mins read

Palantir Stock Gets Fresh $208 Buy Call — But Can It Grow Fast Enough?

NEW YORK, Jan 22, 2026, 13:34 EST

  • Phillip Securities kicked off coverage on Palantir with a “Buy” rating and set a $208 price target.
  • A fresh bullish call emerges amid debate over Palantir’s premium valuation.
  • Contract signals and AI demand are drawing attention as Palantir’s next update approaches, say commentators.

Phillip Securities kicked off coverage of Palantir Technologies on Thursday, assigning a “Buy” rating and setting a $208 price target. Palantir shares were trading near $165 in the U.S. that day. GuruFocus

This call arrives at a tricky time for those who prefer straightforward stories. Palantir’s recent surge has spotlighted the price investors are paying per dollar of sales and profit—and what the company must achieve to prevent that valuation from unraveling.

The market is also wrestling with a familiar challenge in AI stocks: distinguishing real demand from hype-driven prices. Palantir, which provides data-analysis software to government bodies and businesses, has seen renewed interest thanks to its recent AI-focused efforts, bringing it back into the spotlight.

Phillip Securities, in its initiation note, suggested the shares might “re-rate higher” as fundamentals get stronger and the addressable market grows. The firm pointed out that Palantir has grabbed “just” 2.4% of a $119 billion market opportunity it identified back in 2020. It also highlighted that the company’s AI software has been growing at over 25% annually, which could push that market potential even further. TipRanks

On the flip side, a valuation-focused analysis argued the bar is already set high. According to a Motley Fool article, Palantir’s forward price-to-earnings ratio sits around 172, while the stock trades at about 112 times its trailing 12-month sales. Their reverse discounted cash flow model suggests Palantir would need to grow revenue by 30% to 40% annually for several years to justify its current price. CEO Alex Karp dismissed these concerns in November, saying “outsiders” have trouble assessing Palantir’s business. The Motley Fool

Summit Research, writing for Seeking Alpha, looked at Palantir through a different lens, noting it was trading at about 167 times projected earnings over the next twelve months and 64 times expected sales for the same period. The report highlighted “accelerating RPO” — or remaining performance obligations, which means contracted work not yet booked as revenue — as a key indicator, suggesting revenue visibility might extend into upcoming quarters. Seeking Alpha

At the heart of the divide: bulls point to the contract pipeline and AI-driven adoption as sources of ongoing upside surprises, while skeptics counter that even solid execution feels routine when the multiple is already stretched.

The downside risk is clear. If growth slows, big contracts fall through, or margins fall short, the stock’s valuation could shrink quickly — and even minor tweaks to assumptions in models like discounted cash flow can shift “fair value” dramatically.

Phillip’s target edges above the range favored by many analysts, yet the market mood stays wary. The real checkpoint is Palantir’s upcoming quarterly report and 2026 guidance. Investors will be scrutinizing bookings, backlog, and the share of growth driven by steady commercial contracts versus sporadic government projects.

Stock Market Today

  • SpaceX Set to Go Public: Key Details and Market Impact
    May 20, 2026, 8:02 PM EDT. SpaceX, founded by Elon Musk, is poised to go public, joining hundreds of companies that raised $70 billion in U.S. equity markets last year. Going public means the company will offer shares for sale on stock exchanges, allowing investors to buy ownership stakes. This move could unlock significant capital for SpaceX's ambitious space ventures, while providing early investors a chance to realize gains. The offering is closely watched amid a strong appetite for tech and aerospace stocks, reflecting broader market interest in innovation-driven firms.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Accenture stock price rises as Palantir-backed “sovereign AI” data-center deal grabs focus
Previous Story

Accenture stock price rises as Palantir-backed “sovereign AI” data-center deal grabs focus

Nebius (NBIS) stock swings as Israel AI supercomputer launch hits tape, investors eye contract deadlines
Next Story

Nebius (NBIS) stock swings as Israel AI supercomputer launch hits tape, investors eye contract deadlines

Go toTop